McKesson 12-Drug Panel with Adulterants Drugs of Abuse Test (25/BX)

Key Features

SKU: MKS-16-6125A3-BX
Condition: Factory New
Weight: 3.58 lb
All-in-one preliminary screening test for the qualitative detection of multiple drugs and drug metabolites in urine at specific cut-off levels.
CLIA-waved urine drug screen.
Offers panel size up to 12 analytes with an additional three adulteration tests.
Tests for the following drugs, consumption of which is prohibited by the Controlled Substances Act: amphetamines (AMP); barbiturates (BAR); benzodiazepine (BZO); buprenorphine (BUP); cocaine (COC); ecstasy (MDMA), marijuana (THC); methamphetamine (mAMP/MET); methadone (MTD); opiates (MOP300);
Learn more:

Contact The Manufacturer

MFR: McKesson Brand Ships from MFI Medical
MPN: 16-6125A3

$81.87

Shop with Confidence

+

Description

McKesson 12-Drug Panel with Adulterants Drugs of Abuse Test (25/BX)

All-in-one preliminary screening test for the qualitative detection of multiple drugs and drug metabolites in urine at specific cut-off levels.
CLIA-waved urine drug screen.
Offers panel size up to 12 analytes with an additional three adulteration tests.
Tests for the following drugs, consumption of which is prohibited by the Controlled Substances Act: amphetamines (AMP); barbiturates (BAR); benzodiazepine (BZO); buprenorphine (BUP); cocaine (COC); ecstasy (MDMA), marijuana (THC); methamphetamine (mAMP/MET); methadone (MTD); opiates (MOP300); oxycodone (OXY); and PCP (angel dust).
Rapid, visually read results in just 5 minutes.
Of the 12 analytes, specifically, this test cup provides screening for buprenorphine (BUP) and opiates (MOP300) at low-level cut offs.
Built-in specimen validity test (SVT) strip verifies the validity of the specimen to compare with the adulteration color comparison chart card (included).
Oxidants (OX), potential hydrogen (PH) and specific gravity (SG) are detected as a further adulterant check.